Noninvasive risk stratification of patients with transthyretin amyloidosis

JACC: Cardiovascular Imaging

Volumn 7, Issue 5, 2014, Pages 502-510

  Kristen, Arnt V ^a   Scherer, Katrin ^a   Buss, Sebastian ^a   Aus Dem Siepen, Fabian ^a   Haufe, Sabine ^a   Bauer, Ralf ^a   Hinderhofer, Katrin ^a   Giannitsis, Evangelos ^a   Hardt, Stefan ^a   Haberkorn, Uwe ^a   Katus, Hugo A ^a   Steen, Henning ^a  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

cardiac magnetic resonance; echocardiography; skeletal scintigraphy; survival; transthyretin amyloidosis

Indexed keywords

3,3 DIPHOSPHONO 1,2 PROPANODICARBOXYLIC ACID TC 99M; AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; AMYLOID; BIOLOGICAL MARKER; PREALBUMIN; RADIOPHARMACEUTICAL AGENT; TROPONIN T; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BLADDER; CARDIOMYOPATHY; CARDIOVASCULAR MAGNETIC RESONANCE; DIAGNOSTIC TEST ACCURACY STUDY; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; FEMALE; HEART AMYLOIDOSIS; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE HYPERTROPHY; HEART MUSCLE BIOPSY; HUMAN; HUMAN TISSUE; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE SCANNER; POLYNEUROPATHY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SCINTIGRAPHY; SENSITIVITY AND SPECIFICITY; SURVIVAL; TRANSTHYRETIN AMYLOIDOSIS; AGED; AMYLOID NEUROPATHIES, FAMILIAL; BIOPSY; CARDIOMYOPATHIES; CAUSE OF DEATH; COMPLICATION; DIFFERENTIAL DIAGNOSIS; DOPPLER ECHOCARDIOGRAPHY; EPIDEMIOLOGY; FOLLOW UP; GERMANY; METABOLISM; MIDDLE AGED; MORTALITY; NUCLEAR MAGNETIC RESONANCE IMAGING; PROCEDURES; RECEIVER OPERATING CHARACTERISTIC; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SURVIVAL RATE; TRENDS;

AGED; AMYLOID NEUROPATHIES, FAMILIAL; BIOPSY; CARDIOMYOPATHIES; CAUSE OF DEATH; DIAGNOSIS, DIFFERENTIAL; ECHOCARDIOGRAPHY, DOPPLER; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; GERMANY; HUMANS; MAGNETIC RESONANCE IMAGING, CINE; MALE; MIDDLE AGED; PREALBUMIN; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; ROC CURVE; SURVIVAL RATE; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 84900416331     PISSN: 1936878X     EISSN: 18767591     Source Type: Journal    
DOI: 10.1016/j.jcmg.2014.03.002     Document Type: Article

References (42)

1. T. Coelho, M.S. Maurer, and O.B. Suhr THAOS - The Transthyretin Amyloidosis Outcomes Survey: initial report on clinical manifestations in patients with hereditary and wild-type transthyretin amyloidosis Curr Med Res Opin 29 2013 63 76
2. C. Rapezzi, S. Longhi, and A. Milandri et al. Cardiac involvement in hereditary-transthyretin related amyloidosis Amyloid 19 2012 16 21
3. E. Ihse, A. Ybo, O. Suhr, P. Lindqvist, C. Backman, and P. Westermark Amyloid fibril composition is related to the phenotype of hereditary transthyretin V30M amyloidosis J Pathol 216 2008 253 261
4. E. Hund, R.P. Linke, F. Willig, and A. Grau Transthyretin-associated neuropathic amyloidosis. Pathogenesis and treatment Neurology 56 2001 431 435
5. M.J. Saraiva Hereditary transthyretin amyloidosis: molecular basis and therapeutical strategies Expert Rev Mol Med 4 2002 1 11
6. Y. Ando, M. Nakamura, and S. Araki Transthyretin-related familial amyloidotic polyneuropathy Arch Neurol 62 2005 1057 1062
7. L.H. Connors, G. Doros, F. Sam, A. Badiee, D.C. Seldin, and M. Skinner Clinical features and survival in senile systemic amyloidosis: comparison to familial transthyretin cardiomyopathy Amyloid 18 Suppl 1 2011 152 154
8. M.D. Benson Pathogenesis of transthyretin amyloidosis Amyloid 19 2012 14 15
9. J.N. Dungu, L.J. Anderson, C.J. Whelan, and P.N. Hawkins Cardiac transthyretin amyloidosis Heart 98 2012 1546 1554
10. G.G. Cornwell III, W.L. Murdoch, R.A. Kyle, P. Westermark, and P. Pitkanen Frequency and distribution of senile cardiovascular amyloid. A clinicopathologic correlation Am J Med 75 1983 618 623
11. F.L. Ruberg, and J.L. Berk Transthyretin (TTR) cardiac amyloidosis Circulation 126 2012 1286 1300
12. C. Rapezzi, G. Merlini, and C.C. Quarta et al. Systemic cardiac amyloidoses: disease profiles and clinical courses of the 3 main types Circulation 120 2009 1203 1212
13. A.V. Kristen, S. Haufe, and S.O. Schonland et al. Skeletal scintigraphy indicates disease severity of cardiac involvement in patients with senile systemic amyloidosis Int J Cardiol 164 2011 179 184
14. O.B. Suhr, and B.G. Ericzon Selection of hereditary transthyretin amyloid patients for liver transplantation: The Swedish experience Amyloid 19 Suppl 1 2012 78 80
15. A.V. Kristen, J.B. Perz, and S.O. Schonland et al. Rapid progression of left ventricular wall thickness predicts mortality in cardiac light-chain amyloidosis J Heart Lung Transplant 26 2007 1313 1319
16. G. Palladini, C. Campana, and C. Klersy et al. Serum N-terminal pro-brain natriuretic peptide is a sensitive marker of myocardial dysfunction in AL amyloidosis Circulation 107 2003 2440 2445
17. A. Dispenzieri, R.A. Kyle, and M.A. Gertz et al. Survival in patients with primary systemic amyloidosis and raised serum cardiac troponins Lancet 361 2003 1787 1789
18. A.V. Kristen, J. Perz, and S. Schonland et al. Non-invasive predictors of survival in cardiac amyloidosis Eur J Heart Fail 9 2007 617 624
19. M. Puille, K. Altland, and R.P. Linke et al. 99mTc-DPD scintigraphy in transthyretin-related familial amyloidotic polyneuropathy Eur J Nucl Med Mol Imaging 29 2002 376 379
20. E. Perugini, P.L. Guidalotti, and F. Salvi et al. Noninvasive etiologic diagnosis of cardiac amyloidosis using 99mTc-3,3-diphosphono-1,2- propanodicarboxylic acid scintigraphy J Am Coll Cardiol 46 2005 1076 1084
21. A.W. Glaudemans, R.H. Slart, and C.J. Zeebregts et al. Nuclear imaging in cardiac amyloidosis Eur J Nucl Med Mol Imaging 36 2009 702 714
22. K. Altland, M.D. Benson, and C.E. Costello et al. Genetic microheterogeneity of human transthyretin detected by IEF Electrophoresis 28 2007 2053 2064
23. M.A. Gertz, R. Comenzo, and R.H. Falk et al. Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): A consensus opinion from the 10th International Symposium on Amyloid and Amyloidosis Am J Hematol 79 2005 319 328
24. S.J. Khouri, G.T. Maly, D.D. Suh, and T.E. Walsh A practical approach to the echocardiographic evaluation of diastolic function J Am Soc Echocardiogr 17 2004 290 297
25. R.M. Lang, M. Bierig, and R.B. Devereux et al. Recommendations for chamber quantification: A report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology J Am Soc Echocardiogr 18 2005 1440 1463
26. S.F. Nagueh, C.P. Appleton, and T.C. Gillebert et al. Recommendations for the evaluation of left ventricular diastolic function by echocardiography Eur J Echocardiogr 10 2009 165 193
27. N. Reichek, and R.B. Devereux Reliable estimation of peak left ventricular systolic pressure by M-mode echographic-determined end-diastolic relative wall thickness: identification of severe valvular aortic stenosis in adult patients Am Heart J 103 1982 202 203
28. S. Lehrke, H. Steen, and A.V. Kristen et al. Serum levels of NT-proBNP as surrogate for cardiac amyloid burden: new evidence from gadolinium-enhanced cardiac magnetic resonance imaging in patients with amyloidosis Amyloid 16 2009 187 195
29. C. Rapezzi, P. Guidalotti, F. Salvi, L. Riva, and E. Perugini Usefulness of 99mTc-DPD scintigraphy in cardiac amyloidosis J Am Coll Cardiol 51 2008 1509 1510
30. C. Rapezzi, C.C. Quarta, and P.L. Guidalotti et al. Usefulness and limitations of 99mTc-3,3-diphosphono-1,2-propanodicarboxylic acid scintigraphy in the aetiological diagnosis of amyloidotic cardiomyopathy Eur J Nucl Med Mol Imaging 38 2011 470 478
31. R.A. Yood, M. Skinner, A.S. Cohen, and V.W. Lee Soft tissue uptake of bone seeking radionuclide in amyloidosis J Rheumatol 8 1981 760 766
32. F. Minutoli, G. Di Bella, and A. Mazzeo et al. Comparison between (99m)Tc-diphosphonate imaging and MRI with late gadolinium enhancement in evaluating cardiac involvement in patients with transthyretin familial amyloid polyneuropathy AJR Am J Roentgenol 200 2013 W256 W265
33. S. Bokhari, A. Castano, and T. Pzniakoff et al. 99mTc-pyrophosphate scintigraphy for differentiating light-chain cardiac amyloidosis from the transthyretin-related familial and senile cardiac amyloidosis Circ Cardiovasc Imaging 6 2013 195 201
34. G. Palladini, G. Malamani, and F. Co et al. Holter monitoring in AL amyloidosis: prognostic implications Pacing Clin Electrophysiol 24 2001 1228 1233
35. D. Bellavia, P.A. Pellikka, and T.P. Abraham et al. 'Hypersynchronisation' by tissue velocity imaging in patients with cardiac amyloidosis Heart 95 2009 234 240
36. B. Ng, L.H. Connors, R. Davidoff, M. Skinner, and R.H. Falk Senile systemic amyloidosis presenting with heart failure: A comparison with light chain-associated amyloidosis Arch Intern Med 165 2005 1425 1429
37. R.A. Kyle, P.C. Spittell, and M.A. Gertz et al. The premortem recognition of systemic senile amyloidosis with cardiac involvement Am J Med 101 1996 395 400
38. C. Rapezzi, C.C. Quarta, and P.L. Guidalotti et al. Role of (99m)Tc-DPD scintigraphy in diagnosis and prognosis of hereditary transthyretin-related cardiac amyloidosis J Am Coll Cardiol Img 4 2011 659 670
39. A.V. Kristen, E. Giannitsis, and S. Lehrke et al. Assessment of disease severity and outcome in patients with systemic light-chain amyloidosis by the high-sensitivity troponin-T assay Blood 116 2010 2455 2461
40. A. Dispenzieri, M.A. Gertz, and R.A. Kyle et al. Serum cardiac troponins and N-terminal pro-brain natriuretic peptide: A staging system for primary systemic amyloidosis J Clin Oncol 22 2004 3751 3757
41. O.B. Suhr, I. Anan, and C. Backman et al. Do troponin and B-natriuretic peptide detect cardiomyopathy in transthyretin amyloidosis? J Intern Med 263 2007 294 301
42. M. Fontana, S.M. Banypersad, and T.A. Treibel et al. Native t1 mapping in transthyretin amyloidosis J Am Coll Cardiol Img 7 2014 57 65